With 704 measles cases reported since January, Department of Health and Human Services and Centers for Disease Control and Prevention officials today urged vaccination for all eligible children and high-risk adults, including travelers and health care workers. Measles was eliminated in the United States in 2000, making this year’s case count the highest since 1994. The “vast majority” of cases involve children who have not been vaccinated, noted HHS Secretary Alex Azar during a CDC tele-briefing. CDC recommends that children receive the first of two doses of the measles, mumps and rubella vaccine between age 12 and 15 months, or between 6 and 11 months if traveling internationally. The recent outbreaks started when unvaccinated travelers to countries with widespread measles transmission returned to the U.S. and exposed others who were unvaccinated. “There are no treatments and cures for measles and no way to predict how bad a case will be,” said CDC Director Robert Redfield, M.D., noting that possible complications include pneumonia and encephalitis. About 9 percent of Americans infected this year have been hospitalized. CDC’s Advisory Committee on Immunization Practices recommends that health care personnel have documented evidence of immunity against measles. For more on measles, including information for health care professionals, visit https://www.cdc.gov/measles.

Related News Articles

Headline
A study published June 25 by the Journal of the American Heart Association found that heart disease death rates fell 66% from 1970 to 2022. Deaths from heart…
Headline
The White House May 22 released its Make America Healthy Again report that focuses on childhood chronic disease. The report highlights findings from the MAHA…
Headline
The Food and Drug Administration May 16 announced it cleared the first blood test to diagnose Alzheimer’s disease. The test, created by Fujirebio Diagnostics,…
Headline
The National Institutes of Health May 8 released an analysis that found incidences of 14 types of cancer increased among people under age 50 from 2010-2019.…
Headline
A New England Journal of Medicine study published yesterday found success in administering dostarlimab, an immunotherapy drug, to a group of 103 cancer…
Headline
Overall cancer death rates declined steadily among both men and women from 2018 through 2022, according to the National Institutes of Health's latest annual…